Similar articles

• The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome.

  Castinetti F, Brue T, Conte-Devolx B. Castinetti F, et al. Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):295-9. doi: 10.1097/MED.0b013e32835430bf. Curr Opin Endocrinol Diabetes Obes. 2012. PMID: 22543346 Review.
• Mifepristone for management of Cushing's syndrome.

  Morgan FH, Laufgraben MJ. Morgan FH, et al. Pharmacotherapy. 2013 Mar;33(3):319-29. doi: 10.1002/phar.1202. Epub 2013 Feb 21. Pharmacotherapy. 2013. PMID: 23436494 Review.
• A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone.

  Fleseriu M, Molitch ME, Gross C, Schteingart DE, Vaughan TB 3rd, Biller BM. Fleseriu M, et al. Endocr Pract. 2013 Mar-Apr;19(2):313-26. doi: 10.4158/EP12149.RA. Endocr Pract. 2013. PMID: 23337135 Review.
• Mifepristone: treatment of Cushing's syndrome.

  Sartor O, Cutler GB Jr. Sartor O, et al. Clin Obstet Gynecol. 1996 Jun;39(2):506-10. doi: 10.1097/00003081-199606000-00024. Clin Obstet Gynecol. 1996. PMID: 8734015 Review.
• Medical treatment of Cushing's syndrome: glucocorticoid receptor antagonists and mifepristone.

  Castinetti F, Conte-Devolx B, Brue T. Castinetti F, et al. Neuroendocrinology. 2010;92 Suppl 1:125-30. doi: 10.1159/000314224. Epub 2010 Sep 10. Neuroendocrinology. 2010. PMID: 20829633